2 RESISTANCE PHENOTYPES TO BETA-LACTAMS OF ALCALIGENES-DENITRIFICANS SUBSP XYLOSOXYDANS IN RELATION TO BETA-LACTAMASE TYPES

被引：13

作者：

PHILIPPON, A

MENSAH, K

FOURNIER, G

FRENEY, J

机构：

[1] CHU COCHIN,SERV BACTERIOL,F-75014 PARIS,FRANCE

[2] HOP EDOUARD HERRIOT,SERV MICROBIOL,F-69437 LYONS,FRANCE

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 1990年 / 25卷 / 04期

关键词：

D O I：

10.1093/jac/25.4.698

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：698 / 700

页数：3

共 50 条

[31] RESISTANCE PHENOTYPES TO BETA-LACTAMS AND AMINOGLYCOSIDES FOR 270 ENTEROBACTERIACEAE ISOLATED IN PEDIATRICS
BENHASSEN, A
CHOUROU, O
FENDRI, C
KAMMOUN, A
BENREDJEB, S
BULLETIN DE LA SOCIETE DE PATHOLOGIE EXOTIQUE, 1991, 84 (02): : 145 - 153
[32] CP-45,899, A BETA-LACTAMASE INHIBITOR THAT EXTENDS ANTIBACTERIAL SPECTRUM OF BETA-LACTAMS - INITIAL BACTERIOLOGICAL CHARACTERIZATION
ENGLISH, AR
RETSEMA, JA
GIRARD, AE
LYNCH, JE
BARTH, WE
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1978, 14 (03) : 414 - 419
[33] INVITRO EFFECTS OF BETA-LACTAMS COMBINED WITH BETA-LACTAMASE INHIBITORS AGAINST METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS
KOBAYASHI, S
ARAI, S
HAYASHI, S
SAKAGUCHI, T
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (03) : 331 - 335
[34] Acylation of beta-lactams by class A beta-lactamase: An ab initio theoretical study on the effects of the oxy-anion hole
Wladkowski, BD
Chenoweth, SA
Sanders, JN
Krauss, M
Stevens, WJ
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1997, 119 (27) : 6423 - 6431
[35] METAL RESISTANCE IN ACINETOBACTER AND ITS RELATION TO BETA-LACTAMASE PRODUCTION
DESHPANDE, LM
KAPADNIS, BP
CHOPADE, BA
BIOMETALS, 1993, 6 (01) : 55 - 59
[36] BETA-LACTAMASE SUSCEPTIBILITY AND COMPARATIVE ACTIVITY OF SCH-34343 AND OTHER BETA-LACTAMS FOR NON-FERMENTERS, NEISSERIA SPP AND BETA-LACTAMASE-POSITIVE ENTEROBACTERIACEAE
MOUTON, RP
MULDERS, SLTA
VANGESTEL, MH
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1985, 15 : 111 - 117
[37] Which proportion of extended-spectrum beta-lactamase producing strains could be treated by non-carbapenem beta-lactams?
Canoui, E.
Tankovic, J.
Bige, N.
Alves, M.
Offenstadt, G.
MEDECINE ET MALADIES INFECTIEUSES, 2014, 44 (05): : 235 - 237
[38] POTENT MECHANISM-BASED INHIBITION OF THE TEM-1 BETA-LACTAMASE BY NOVEL N-SULFONYLOXY BETA-LACTAMS
BULYCHEV, A
OBRIEN, ME
MASSOVA, I
TENG, M
GIBSON, TA
MILLER, MJ
MOBASHERY, S
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1995, 117 (22) : 5938 - 5943
[39] ANTIBODIES AGAINST PSEUDOMONAS-AERUGINOSA CHROMOSOMAL BETA-LACTAMASE IN PATIENTS WITH CYSTIC-FIBROSIS ARE MARKERS OF THE DEVELOPMENT OF RESISTANCE OF PSEUDOMONAS-AERUGINOSA TO BETA-LACTAMS
CIOFU, O
GIWERCMAN, B
WALTERRASMUSSEN, J
PRESSLER, T
PEDERSEN, SS
HOIBY, N
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1995, 35 (02) : 295 - 304
[40] Comparative activity of beta-lactams against Pseudomonas aeruginosa according to resistance phenotypes.
Bert, F
Briaud, I
Branger, C
LambertZechovsky, N
PATHOLOGIE BIOLOGIE, 1996, 44 (05): : 329 - 332

← 1 2 3 4 5 →